IT1254627B - Steroid formulations - Google Patents

Steroid formulations

Info

Publication number
IT1254627B
IT1254627B ITMI920393A ITMI920393A IT1254627B IT 1254627 B IT1254627 B IT 1254627B IT MI920393 A ITMI920393 A IT MI920393A IT MI920393 A ITMI920393 A IT MI920393A IT 1254627 B IT1254627 B IT 1254627B
Authority
IT
Italy
Prior art keywords
formulation
steroid formulations
steroid
formulations
allergic
Prior art date
Application number
ITMI920393A
Other languages
Italian (it)
Inventor
Joy Elaine Saunders
Original Assignee
Fisons
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons filed Critical Fisons
Publication of ITMI920393A0 publication Critical patent/ITMI920393A0/en
Publication of ITMI920393A1 publication Critical patent/ITMI920393A1/en
Application granted granted Critical
Publication of IT1254627B publication Critical patent/IT1254627B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

Formulation of an aqueous suspension containing tipredane as the main active ingredient. The formulation is useful for the treatment of nasal conditions to which allergic or immunological reactions contribute.
ITMI920393A 1991-02-23 1992-02-21 Steroid formulations IT1254627B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919103824A GB9103824D0 (en) 1991-02-23 1991-02-23 Formulation
PCT/GB1992/000290 WO1992014473A1 (en) 1991-02-23 1992-02-19 Steroid formulations

Publications (3)

Publication Number Publication Date
ITMI920393A0 ITMI920393A0 (en) 1992-02-21
ITMI920393A1 ITMI920393A1 (en) 1993-08-21
IT1254627B true IT1254627B (en) 1995-09-28

Family

ID=10690478

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI920393A IT1254627B (en) 1991-02-23 1992-02-21 Steroid formulations

Country Status (13)

Country Link
CN (1) CN1065010A (en)
AU (1) AU1247192A (en)
BE (1) BE1004177A4 (en)
FR (1) FR2673104A1 (en)
GB (1) GB9103824D0 (en)
GR (1) GR1001511B (en)
IE (1) IE920516A1 (en)
IL (1) IL101010A0 (en)
IT (1) IT1254627B (en)
MX (1) MX9200748A (en)
PT (1) PT100150A (en)
WO (1) WO1992014473A1 (en)
ZA (1) ZA921247B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0551626A1 (en) * 1991-12-19 1993-07-21 LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d. Thermoreversible gel as a liquid pharmaceutical carrier for a galenic formulation
US5976573A (en) * 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
JP2005281315A (en) * 1997-07-02 2005-10-13 Aventis Pharmaceuticals Holdings Inc Aqueous pharmacological composition
TWI243687B (en) * 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
US20030059440A1 (en) * 1998-09-01 2003-03-27 Tim Clarot Composition and method for moisturizing nasal tissue
AR026073A1 (en) 1999-10-20 2002-12-26 Nycomed Gmbh PHARMACEUTICAL COMPOSITION AQUATIC CONTAINING CICLESONIDE
AR026072A1 (en) * 1999-10-20 2002-12-26 Nycomed Gmbh PHARMACEUTICAL COMPOSITION CONTAINING CICLESONIDE FOR MUCOSA APPLICATION
DE10064950A1 (en) * 2000-12-23 2002-07-11 Impetus Ag Basel Thixotropic nasal spray
EP1645266A1 (en) * 2004-10-08 2006-04-12 Hisamitsu Medical Co., Ltd. Aqueous suspension for nasal drops
EP2057982A1 (en) * 2007-11-09 2009-05-13 Archimedes Development Limited Intranasal compositions
WO2013049539A1 (en) * 2011-09-30 2013-04-04 Mcneil-Ppc, Inc. A method of blocking or trapping allergens
EP3694524A1 (en) * 2017-10-11 2020-08-19 Lifescience AS N-acetylneuraminic acid compositions and methods of use
WO2020165578A1 (en) * 2019-02-11 2020-08-20 Reckitt Benckiser Health Limited Novel composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4361559A (en) * 1981-08-20 1982-11-30 E. R. Squibb & Sons, Inc. Antiinflammatory 17,17-bis (substituted thio) androstenes
US4782047A (en) * 1986-05-22 1988-11-01 Syntex Pharmaceuticals International Ltd. Aqueous steroid formulations for nasal administration
US4868170A (en) * 1987-11-13 1989-09-19 E. R. Squibb & Sons, Inc. Steriod lotion formulation
IE67185B1 (en) * 1990-02-02 1996-03-06 Fisons Plc Propellant compositions

Also Published As

Publication number Publication date
ITMI920393A0 (en) 1992-02-21
FR2673104A1 (en) 1992-08-28
BE1004177A4 (en) 1992-10-06
ITMI920393A1 (en) 1993-08-21
ZA921247B (en) 1992-10-28
IL101010A0 (en) 1992-11-15
GB9103824D0 (en) 1991-04-10
AU1247192A (en) 1992-09-15
GR1001511B (en) 1994-02-28
PT100150A (en) 1993-05-31
CN1065010A (en) 1992-10-07
WO1992014473A1 (en) 1992-09-03
IE920516A1 (en) 1992-08-26
MX9200748A (en) 1992-10-01

Similar Documents

Publication Publication Date Title
IT1254627B (en) Steroid formulations
HRP920667A2 (en) Application of fultripine active substance for preventing muscle deformation
GR3036655T3 (en) Use of IL-4 receptors for the therapy, prophylaxis and diagnosis of allergic, viral, paracitic and bacterial diseases, as well as of fungal infections.
EP0209689A3 (en) Use of tetrahydrobiopterins in the treatment of infantile autism
AU561016B2 (en) N-glycosylated carboxamide derivatives
ES2063146T3 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING N- (3,4-DIMETOXICINAMOIL) -ANTRANILICO ACID.
DE3381396D1 (en) FORMULATION OF NON-IRRITATING OPHTHALMIC AQUEOUS COMPOSITIONS FOR OKULAR THERAPEUTIC AGENTS.
EP0444196A4 (en) Agent for treatment and prophylaxis of ischemic disease of heart or brain
MY115339A (en) Compositions containing micronized nebivolol
UA37259C2 (en) Active substance for pharmaceutical compositions intended for treatment of dysfunctional metrorrhagia
ZA947957B (en) Substituted 1-naphthyl-3-pyrazolecarboxamides which are active in neurotensin their preparation and pharmaceutical compositions containing them
ZA826453B (en) Tricyclic thiazolyloxamic acids and their derivatives,their preparation,and therapeutic agents containing these compounds
ZA877454B (en) Therapeutic agent for the treatment of peptic ulcer disease
AU5259486A (en) Arylalkoxyphenyl-allylic alcohols as agents for the treatment of hypersensitive ailments
SE8107816L (en) AGENTS FOR LOCAL TREATMENT OF PAVERCAN FROM SEBORRE ON HUMAN HEALTH
IL87867A0 (en) Preparation of pharmaceutical compositions containing a 2,6-diamino-pyridine derivatives
NO169713C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 4-ARYL CARBONYL-1 - ((4-MORPHOLINYL) ALKYL) -1H-INDOLES.
IT1255696B (en) Compound having vasodilatory activity, process for its preparation and pharmaceutical compositions containing it.
KR880012228A (en) Asthma Remedies
AU577570B2 (en) Mefloquine quinates
IT1248525B (en) Derivatives of eseridine useful for the treatment of diseases associated with cholinergic disorders, process for their preparation and pharmaceutical compositions which contain them

Legal Events

Date Code Title Description
0001 Granted